STAT+: Tapping the potential of GLP-1 drugs requires integrated care and overcoming inequities, executives say

At STAT's Breakthrough Summit East, the CEOs of Ro and Included Health said the the U.S. health care system poses obstacles to maximizing the potential of GLP-1 drugs.